EFfects of Y-6 SUblingual Tablets foR PaTients With AcUte Ischemic StRokE (FUTURE)

NCT06138834 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

300

Enrollment

OTHER

Sponsor class

Conditions

Acute Ischemic Stroke
Large Vessel Occlusion
Reperfusion

Interventions

DRUG: Low-dose Y-6 sublingual tablets
DRUG: High-dose Y-6 sublingual tablets
DRUG: Low-dose Cilostazol
DRUG: High-dose Cilostazol
DRUG: Placebo

Sponsor

Beijing Tiantan Hospital

Collaborators

[object Object]